A Recurrent De Novo Heterozygous COG4 Substitution Leads to Saul-Wilson Syndrome, Disrupted Vesicular Trafficking, and Altered Proteoglycan GlycosylationCarlos R. Ferreira, Andrew P. Jackson, Prashant Sharma et al.|The American Journal of Human Genetics|2018Cited by 76
Predominant and novel de novo variants in 29 individuals with <scp><i>ALG13</i></scp> deficiency: Clinical description, biomarker status, biochemical analysis, and treatment suggestionsBobby G. Ng, Lynne A. Wolfe, Erik A. Eklund et al.|Journal of Inherited Metabolic Disease|2020Cited by 39
Defining the clinical phenotype of Saul–Wilson syndromeCarlos R. Ferreira, Michael B. Bober, Wadih M. Zein et al.|Genetics in Medicine|2020Cited by 21